MERIT acquires OSOD to aid in early stage drug development

News
Article

Ocular Services On Demand (OSOD) has operated for over 30 years in ophthalmic preclinical drug development.

Business leaders at table with paperwork Image credit: AdobeStock/Panumas

Image credit: AdobeStock/Panumas

Global clinical trial endpoint and technology services provider MERIT announced that the company has acquired Ocular Services On Demand (OSOD), a consortium of vision science and ocular development experts.1 According to a news release, the acquisition was completed with the goal of enhancing MERIT’s service offerings and allowing for successful transitions from preclinical to clinical phases of drug development.

“MERIT is delighted to welcome OSOD to our family. This acquisition represents a significant milestone in our mission to advance drug development and deliver life-changing therapies to patients worldwide,” said Yijun Huang, CEO of MERIT, in the release. “Together, we will set new standards in the industry and drive forward the future of medicine.”

OSOD has operated for over 30 years in ophthalmic preclinical drug development, having influenced the advancements of several ophthalmic therapies from preclinical research to market approval. A handful of those therapies include Lucentis, Eylea, Xiidra, Susvimo, and Durysta.1

“OSOD has always been committed to excellence in early-stage ophthalmology research. Joining forces with MERIT allows us to extend our impact and contribute to the entire drug development continuum,” said Christopher Murphy, CEO of OSOD, in the release. “Importantly, the entire management team, employees and our distributed network of experts in vision science and drug development remain committed to advancing the impact of OSOD in ocular drug development. We look forward to leveraging the resources and capabilities of MERIT to the benefit of our clients in bringing much needed therapeutics to the marketplace to benefit patients. We look forward to a collaborative and innovative future.”

Reference:
  1. MERIT acquires OSOD, expanding capabilities in early-stage drug development. News release. January 22, 2025. Accessed January 22, 2025. https://meritcro.com/news/merit-acquires-osod-expanding-capabilities-in-early-stage-drug-development/
Recent Videos
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
Agatha Sleboda, OD; Arti Shah, OD, FAAO; and Kent J. Nozacki, OD provide the best tips that they give to their patients during natural disasters events in light of the recent Greater Los Angeles wildfires.
Optometrists local to the Los Angeles area overview their efforts to continue providing support to patients affected by January's wildfires.
Brianna Rhue, OD, FAAO, FSLS, reviewed key takeaways from The Future of Myopia Management: Perspectives from Leading Experts talk from SECO 2025.
Robert L. Stamper, MD, overviews his optometric track talk titled Objective Perimetry - Can you see it? at this year's Glaucoma 360 meeting.
Yvonne Ou, MD, outlined lifestyle modifications for glaucoma management that have proven beneficial, including yoga and cycling.
Robert L. Stamper, MD, weighs in on what he think more optometrists should know about glaucoma and current misconceptions concerning glaucoma testing.
John Berdahl, MD, overviews the new FYXS Ocular Pressure Adjusting Pump and HERCULES trial at the Glaucoma 360 meeting.
Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, weighs in on what's on the horizon for pediatric myopia management, and provides some tips for diving into scleral lens fitting.
Shan Lin, MD, outlines a new generation of minimally invasive glaucoma surgeries (MIGS) at Glaucoma 360.
Related Content
Doctor with referral note Image credit: AdobeStock/thodonal

New study finds low diagnostic rates for patients with glaucoma referrals

Jordana Joy, Associate Editor
March 13th 2025
Article
Debunking common ortho-k myths

Debunking common ortho-k myths

Kassi Jackson Filkins, Editor;Chandra Mickles, OD, MS, FAAO, FSLS
October 6th 2022
Podcast
Businessmen shaking hands with digital graphic overlay Image credit: AdobeStock/Vittaya_25

Topcon Healthcare, RadiusXR, and Glaukos enter into a collaboration

Jordana Joy, Associate Editor
March 12th 2025
Article
VEW 2022: Guess again, your child is NOT too young for contact lenses

VEW 2022: Guess again, your child is NOT too young for contact lenses

Vittorio Mena, OD, MS,;Kassi Jackson Filkins, Editor
September 15th 2022
Podcast
Older woman holding cup looking out window Image credit: AdobeStock/VadimPastuh

Genetic risk for glaucoma increases with age

Lynda Charters
March 11th 2025
Article
Woman with eye pain touching head Image credit: AdobeStock/DimaBerlin

OKYO Pharma files Fast Track designation application with the FDA for urcosimod for the treatment of NCP

Martin David Harp, Associate Editor, Ophthalmology Times
March 10th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.